tyb
SAM905 USAF G5 ne from JBA across the pond-this AC went to Atlantic City Int'l for fly-bys as VENUS62 earlier today
Italian AF IAM3170 Falcon 900 west from Novosibirsk, Russia (inbound trip yesterday) and IAM1431 KC-767A tanker nw from Beirut Int'l
Pakistani AF BURQ303 G4 sw from Lahore
Not often are these visible
GRZLY50 USMC C-560 on descent to JBA departed MCAS Miramar and ground stops at Phoenix, AR-Sky Harbor and Wichita, KS-Eisenhower Airport. Same thing for this AC yesterday
Mexico revokes license of savings bank arm of Grupo Famsa
MEXICO CITY, June 30 (Reuters) - Mexican financial authorities said on Tuesday they had revoked the license of the savings bank arm of retailer Grupo Famsa, which last week announced it was seeking Chapter 11 bankruptcy protection in the United States.
In a statement, the financial authorities said the license for Banco Ahorro Famsa had been withdrawn due to inappropriate risk management and operations, as well as loans granted to “related parties of the group above regulatory limits.”
The bank had also kept improper records, and repeatedly failed to comply with regulatory provisions, the central bank, the finance ministry and banking regulator said jointly.
https://www.reuters.com/article/grupo-famsa-bank/mexico-revokes-license-of-savings-bank-arm-of-grupo-famsa-idUSL1N2E801L
several Mexican Fiance news items today
Finally getting a hold of things it seems
Takeda Pharmaceuticals sold Translate Bio, Inc: $141.14m-June 30
This statement is being filed jointly by Shire Human Genetic Therapies, Inc. and Takeda Pharmaceutical Company Limited. Shire is owned by Takeda who had $38m given to them by the Gates Foundation in 2016.
Takeda Receives $38 Million Grant from the Bill & Melinda Gates Foundation to Support Polio Eradication in Developing Countries
https://www.takeda.com/newsroom/newsreleases/2016/takeda-receives-$38-million-grant-from-the-bill–melinda-gates-foundation-to-support-polio-eradication-in-developing-countries/
Translate Bio, Inc. is a messenger RNA, or mRNA, therapeutics company. The Company is developing medicines to treat diseases caused by protein or gene dysfunction. The Company is using its proprietary mRNA therapeutic platform, or MRT platform, and it create mRNA that encodes functional proteins. The mRNA is delivered to the target cell where the cell’s own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. The MRT product candidate for the lung, MRT5005, is designed to address the underlying cause of CF by delivering mRNA encoding fully functional CFTR protein to the lung epithelial cells through nebulization. Number of employees : 93 people.
https://www.marketscreener.com/TRANSLATE-BIO-INC-44403605/company/
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical and biopharmaceutical company. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology.Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States
https://www.finviz.com/insidertrading.ashx?oc=1745009&tc=7&b=2
Carlyle to buy 25% of Bharti Airtel's data center arm for $235 million
BENGALURU (Reuters) - Carlyle will buy a 25% stake in Indian telecom firm Bharti Airtel Ltd’s data center arm for $235 million, the U.S. private equity group said on Wednesday, as it taps into the rapid growth of digital services in India.
The acquisition, by an affiliate of Carlyle, will give Airtel’s Nxtra Data Ltd an enterprise valuation of about $1.2 billion, the companies said in a statement. Airtel will hold the remaining 75% stake in Nxtra. Nxtra, which is building multiple large data centres across India, will use the proceeds from the deal to scale up its infrastructure, the companies said.
India is seeing a surge in demand for data centres as more businesses choose cloud computing, and consumer demand for digital services such as smartphone entertainment continues to grow, they added. Cloud and entertainment services represent the next revenue frontier for traditional telecom carriers like Airtel, as voice and data rates in India remain among the cheapest in the world.
Airtel’s local rival Jio, controlled by billionaire Mukesh Ambani, has a cloud tie-up with Microsoft, under which it will build data centers hosted on Microsoft’s Azure cloud.
https://www.reuters.com/article/us-bharti-airtel-stake-carlyle-group/carlyle-to-buy-25-of-bharti-airtels-data-center-arm-for-235-million-idUSKBN24248T